Developer docs
API playgroundTry for free, no card

Search company profiles

RadLogics

Full company profile

uuid0006ve7

Namestring
RadLogics
Legal namestring
RADLogics
Websiteurl
radlogics.com
Company typeenum
Private
Founded yearint
2010
Descriptiontext

RadLogics is a privately held US medical-imaging analytics company founded in 2010 that operates the patented OmniPoint AI Platform to analyze archived CT, MRI, and PET scans alongside structured and unstructured electronic health record data. Its core function is to surface previously unidentified cancer findings in imaging archives and to flag patients at elevated cancer risk for oncologist review, using a four-stage workflow of PACS/EHR data ingestion, AI analysis, clinical validation, and patient outreach. The platform is differentiated by its retrospective "missed-finding" positioning and by a proprietary sequential AI risk-scoring methodology for malignancy prediction in indeterminate lung nodules, supported by granted US and Japan patents and peer-reviewed clinical publications.

The company sells to a single primary vertical — cancer centers and hospital oncology departments — via direct enterprise sales, integrating its platform with customers' existing PACS and EHR systems and pricing on a quote-based, recurring subscription basis. No public pricing tiers, customer logos, or revenue figures are disclosed. RadLogics is governed by New York law, is led by four co-founders (Moshe Becker as Chairman, Hayit Greenspan PhD as Chief Scientist, Lev Ayzenberg as CTO, and James Gallagher as CFO) plus a co-founder Chief Medical Officer, and has raised approximately $2.85M across two disclosed funding rounds (2011 seed and 2014 round led by Omninet Capital and Winnovation).

The business is small — 11–50 employees — with no disclosed institutional investors beyond the 2014 round and no subsequent funding events in the input data. Geographic scope is stated as the United States only, and the company's marketing centers on enterprise demo requests, clinical publications, and B2B channels such as LinkedIn and YouTube rather than broad distribution partnerships.

Short descriptiontext

RadLogics is a privately held US healthcare-AI company that applies its patented OmniPoint AI Platform to archived CT, MRI, and PET scans and EHR data to surface previously unidentified cancer findings, selling on a subscription basis to cancer centers via direct enterprise sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical imaging analytics, AI cancer detection, radiology AI platform, oncology software, clinical decision support
Industry2 codes
PRIMARYHLABABAI
Sleep & Airway Orthodontics (OSA Appliances/Expansion)
Healthcare & Life Sciences/Dental Care Services/Orthodontics & Dentofacial Orthopedics
SECONDARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance
NAICS code1 code
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Misc Health & Allied Services, Nec8090
Product category
Medical Imaging AI / Oncology Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AI-Powered Cancer Detection Platform
TypeSubscription Recurring
Description

RADLogics provides AI analysis services to cancer centers, connecting to their PACS and EHR systems to analyze archived imaging and medical records. The company generates revenue by helping cancer centers surface unidentified cancers, which drives new patient encounters and measurable revenue for the centers while mitigating risk and liability exposure.

radlogics.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

RadLogics provides the OmniPoint™ AI platform, which connects to cancer centers' PACS and EHR systems to analyze archived CT, MRI, and PET scans along with structured and unstructured medical records data. The platform flags previously unidentified cancer findings that meet clinical significance thresholds and routes them to oncologists for clinical review, after which patient outreach workflows are triggered.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Published clinical evidence through peer-reviewed publications including evaluation of sequential AI risk scoring for malignancy prediction in indeterminate lung nodules
Product overview1 text field

RADLogics offers a single unified product platform called OmniPoint™ AI, which provides end-to-end AI-powered cancer discovery. The platform combines AI image analysis (applying advanced algorithms to CT, MRI, and PET scans) and medical records analysis (processing structured and unstructured EHR data) within a four-stage workflow: Data Ingestion (connecting to PACS and EHR systems), AI Analysis (flagging clinically significant findings), Clinical Review (routing to oncologists for validation), and Patient Outreach (connecting at-risk patients with care).

Product and service1 record
1OmniPoint™ AI Platform
CategoryAI Medical Imaging Analytics
Description

Patented AI platform that connects to existing PACS and EHR systems to analyze archived CT, MRI, and PET imaging alongside structured and unstructured medical records. It flags cancer findings meeting clinical significance thresholds and routes them to oncologists for clinical validation before triggering patient outreach workflows. Built for hospitals with oncology departments and dedicated cancer centers.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

iCAD provides AI-based cancer detection and radiation therapy solutions across mammography, CT, and X-ray. It is a broader incumbent in oncology imaging AI with a wider product portfolio than RADLogics' focused offering.

TypeDirect peer
Description

Aidoc provides AI-driven medical imaging analysis for CT and other modalities, integrated with PACS and EHR workflows. It is a direct competitor in AI radiology analytics and shares RADLogics' enterprise go-to-market with hospitals and healthcare systems.

TypeDirect peer
Description

DeepHealth builds AI tools for radiology workflow, image analysis, and cancer screening across modalities. Its focus on oncology screening and retrospective analysis directly parallels RADLogics' archived-data cancer detection value proposition.

TypeDirect peer
Description

Arterys delivers AI-powered medical imaging analytics with cloud-based PACS integration and AI marketplaces for radiology, aligning closely with RADLogics' approach of integrating AI into imaging workflows for clinical decision support.

5Tempus Labs
TypeEmerging player
Description

Tempus combines molecular and clinical data with AI for precision oncology. While its core is molecular profiling, its data-platform approach to oncology decision support makes it a thematic emerging peer to RADLogics' data-driven cancer discovery model.

TypeBroad incumbent
Description

Google Health and DeepMind produce foundational AI models for medical imaging, including mammography and radiology. It is a broad incumbent whose general-purpose imaging AI could compress the differentiated space RADLogics occupies.

TypeDirect peer
Description

Riverain Technologies applies AI to chest imaging (CT and X-ray) to improve lung nodule detection and oncology workflow — directly overlapping with RADLogics' lung nodule malignancy risk scoring capabilities.

TypeDirect peer
Description

Viz.ai offers AI-powered imaging analysis that flags suspected findings and routes them to specialists for clinical review — closely paralleling RADLogics' flagged-finding → oncologist → patient outreach workflow, particularly in time-sensitive disease areas.

9Zebra Medical Vision
TypeDirect peer
Description

Zebra Medical Vision (now part of Nanox) develops AI algorithms for analyzing CT, MRI, and other imaging modalities to surface findings at scale. It competes directly with RADLogics in retrospective and population-level image analytics.

TypeBroad incumbent
Description

IBM Watson Health (now Merative) offers enterprise imaging AI and clinical decision support tools across radiology and oncology. Its scale and enterprise distribution make it a broad competitive force in healthcare AI imaging.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

RadLogics

Medical Imaging AI / Oncology Softwareradlogics.com

RadLogics is a privately held US healthcare-AI company that applies its patented OmniPoint AI Platform to archived CT, MRI, and PET scans and EHR data to surface previously unidentified cancer findings, selling on a subscription basis to cancer centers via direct enterprise sales.

What RadLogics does

RadLogics is a privately held US medical-imaging analytics company founded in 2010 that operates the patented OmniPoint AI Platform to analyze archived CT, MRI, and PET scans alongside structured and unstructured electronic health record data. Its core function is to surface previously unidentified cancer findings in imaging archives and to flag patients at elevated cancer risk for oncologist review, using a four-stage workflow of PACS/EHR data ingestion, AI analysis, clinical validation, and patient outreach. The platform is differentiated by its retrospective "missed-finding" positioning and by a proprietary sequential AI risk-scoring methodology for malignancy prediction in indeterminate lung nodules, supported by granted US and Japan patents and peer-reviewed clinical publications.

The company sells to a single primary vertical — cancer centers and hospital oncology departments — via direct enterprise sales, integrating its platform with customers' existing PACS and EHR systems and pricing on a quote-based, recurring subscription basis. No public pricing tiers, customer logos, or revenue figures are disclosed. RadLogics is governed by New York law, is led by four co-founders (Moshe Becker as Chairman, Hayit Greenspan PhD as Chief Scientist, Lev Ayzenberg as CTO, and James Gallagher as CFO) plus a co-founder Chief Medical Officer, and has raised approximately $2.85M across two disclosed funding rounds (2011 seed and 2014 round led by Omninet Capital and Winnovation).

The business is small — 11–50 employees — with no disclosed institutional investors beyond the 2014 round and no subsequent funding events in the input data. Geographic scope is stated as the United States only, and the company's marketing centers on enterprise demo requests, clinical publications, and B2B channels such as LinkedIn and YouTube rather than broad distribution partnerships.

RadLogics firmographics

Firmographics
Name
RadLogics
Legal name
RADLogics
Website
https://radlogics.com
Company type
Private
Founded year
2010
Operating status
Operating
Headcount range
1–10 employees
Short description
RadLogics is a privately held US healthcare-AI company that applies its patented OmniPoint AI Platform to archived CT, MRI, and PET scans and EHR data to surface previously unidentified cancer findings, selling on a subscription basis to cancer centers via direct enterprise sales.
Ownership category
akta.pro rank

RadLogics industry classification

Industry
Product category
Medical Imaging AI / Oncology Software
NAICS
Medical and Diagnostic Laboratories (62151)
SIC
Services-Misc Health & Allied Services, Nec (8090)
akta.pro industry
PRIMARYHLABABAI
Sleep & Airway Orthodontics (OSA Appliances/Expansion)
Healthcare & Life Sciences/Dental Care Services/Orthodontics & Dentofacial Orthopedics
SECONDARYHLACAIAJ
Real-World Data (RWD) Platforms & Clinical Data Curation
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare Data Platforms, Warehousing & Governance

Keywords

  • Medical imaging analytics
  • AI cancer detection
  • Radiology AI platform
  • Oncology software
  • Clinical decision support

Where RadLogics is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

RadLogics business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. AI-Powered Cancer Detection Platform: RADLogics provides AI analysis services to cancer centers, connecting to their PACS and EHR systems to analyze archived imaging and medical records. The company generates revenue by helping cancer centers surface unidentified cancers, which drives new patient encounters and measurable revenue for the centers while mitigating risk and liability exposure.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

RadLogics product offering

Product offering

Core offering

RadLogics provides the OmniPoint™ AI platform, which connects to cancer centers' PACS and EHR systems to analyze archived CT, MRI, and PET scans along with structured and unstructured medical records data. The platform flags previously unidentified cancer findings that meet clinical significance thresholds and routes them to oncologists for clinical review, after which patient outreach workflows are triggered.

Product overview

RADLogics offers a single unified product platform called OmniPoint™ AI, which provides end-to-end AI-powered cancer discovery. The platform combines AI image analysis (applying advanced algorithms to CT, MRI, and PET scans) and medical records analysis (processing structured and unstructured EHR data) within a four-stage workflow: Data Ingestion (connecting to PACS and EHR systems), AI Analysis (flagging clinically significant findings), Clinical Review (routing to oncologists for validation), and Patient Outreach (connecting at-risk patients with care).

Differentiator

Problem solved

Functional benefit

Products and services

  • OmniPoint™ AI Platform Patented AI platform that connects to existing PACS and EHR systems to analyze archived CT, MRI, and PET imaging alongside structured and unstructured medical records. It flags cancer findings meeting clinical significance thresholds and routes them to oncologists for clinical validation before triggering patient outreach workflows. Built for hospitals with oncology departments and dedicated cancer centers.

Quantifiable outcome

  • Published clinical evidence through peer-reviewed publications including evaluation of sequential AI risk scoring for malignancy prediction in indeterminate lung nodules

Companies that use RadLogics

Customer profile

Segments1 record

Ideal customer profiles1 record

RadLogics technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature2 records

RadLogics partnerships and signals

Strategic signal

Recent moves5 records

Expansion highlights4 records

RadLogics competitors and assessment

Company assessment

Broad incumbents

  • iCAD: iCAD provides AI-based cancer detection and radiation therapy solutions across mammography, CT, and X-ray. It is a broader incumbent in oncology imaging AI with a wider product portfolio than RADLogics' focused offering.
  • Google Health (Google DeepMind): Google Health and DeepMind produce foundational AI models for medical imaging, including mammography and radiology. It is a broad incumbent whose general-purpose imaging AI could compress the differentiated space RADLogics occupies.
  • IBM Watson Health (Merative): IBM Watson Health (now Merative) offers enterprise imaging AI and clinical decision support tools across radiology and oncology. Its scale and enterprise distribution make it a broad competitive force in healthcare AI imaging.

Direct peers

  • Aidoc: Aidoc provides AI-driven medical imaging analysis for CT and other modalities, integrated with PACS and EHR workflows. It is a direct competitor in AI radiology analytics and shares RADLogics' enterprise go-to-market with hospitals and healthcare systems.
  • DeepHealth (a RadNet company): DeepHealth builds AI tools for radiology workflow, image analysis, and cancer screening across modalities. Its focus on oncology screening and retrospective analysis directly parallels RADLogics' archived-data cancer detection value proposition.
  • Arterys: Arterys delivers AI-powered medical imaging analytics with cloud-based PACS integration and AI marketplaces for radiology, aligning closely with RADLogics' approach of integrating AI into imaging workflows for clinical decision support.
  • Riverain Technologies: Riverain Technologies applies AI to chest imaging (CT and X-ray) to improve lung nodule detection and oncology workflow — directly overlapping with RADLogics' lung nodule malignancy risk scoring capabilities.
  • Viz.ai: Viz.ai offers AI-powered imaging analysis that flags suspected findings and routes them to specialists for clinical review — closely paralleling RADLogics' flagged-finding → oncologist → patient outreach workflow, particularly in time-sensitive disease areas.
  • Zebra Medical Vision: Zebra Medical Vision (now part of Nanox) develops AI algorithms for analyzing CT, MRI, and other imaging modalities to surface findings at scale. It competes directly with RADLogics in retrospective and population-level image analytics.

Emerging players

  • Tempus Labs: Tempus combines molecular and clinical data with AI for precision oncology. While its core is molecular profiling, its data-platform approach to oncology decision support makes it a thematic emerging peer to RADLogics' data-driven cancer discovery model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

RadLogics social profiles

Digital presence

RadLogics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

RadLogics leadership team

Management profile

Number of profiles

Profiles5 records

RadLogics funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

RadLogics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about RadLogics

What does RadLogics do?

RadLogics provides the OmniPoint™ AI platform, which connects to cancer centers' PACS and EHR systems to analyze archived CT, MRI, and PET scans along with structured and unstructured medical records data. The platform flags previously unidentified cancer findings that meet clinical significance thresholds and routes them to oncologists for clinical review, after which patient outreach workflows are triggered.

Is RadLogics a public or private company?

RadLogics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was RadLogics founded?

RadLogics was founded in 2010. It employs 1 to 10 people.

Where is RadLogics based?

RadLogics is headquartered in New York, United States, in the North America region.

How does RadLogics make money?

One revenue line is on record: AI-Powered Cancer Detection Platform.

Who are RadLogics's main competitors?

Broad incumbents on record are iCAD, Google Health (Google DeepMind) and IBM Watson Health (Merative). Direct peers are Aidoc, DeepHealth (a RadNet company), Arterys, Riverain Technologies, Viz.ai and Zebra Medical Vision. Tempus Labs is listed as an emerging player.

Does RadLogics have an API?

No public API is recorded for RadLogics.

What industry is RadLogics in?

RadLogics's product category is Medical Imaging AI / Oncology Software. Its primary akta.pro industry code is HLABABAI, Sleep & Airway Orthodontics (OSA Appliances/Expansion), with a secondary code of HLACAIAJ, Real-World Data (RWD) Platforms & Clinical Data Curation. Its NAICS code is 62151 and its SIC code is 8090.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Imaging Technology NewsRadiologists Urge Use of Medical Imaging and AI-Powered Solutions to Manage COVID-19RADLogics is urging U.S. clinicians to adopt AI-powered medical imaging solutions to manage the surge of COVID-19 patients and alleviate pressure on healthcare systems. The company's AI technology has processed hundreds of thousands of cases globally, providing quantitative analysis to help triage patients and predict disease trajectories. RADLogics remains committed to deploying these FDA-compliant CT and X-ray solutions in the U.S. to support hospitals during the anticipated second wave of the pandemic.Imaging Technology NewsRADLogics FDA Cleared for Novel AI-powered Chest X-ray ApplicationRADLogics announced that its AI-powered chest X-ray application for detecting pneumothorax has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The software, available via the Nuance AI Marketplace, is designed to integrate into clinical workflows to prioritize suspected cases for urgent radiologist review. This regulatory approval allows healthcare providers in the U.S. to deploy the solution immediately to support acute care teams during the ongoing pandemic.PrwebRADLogics Announces FDA Clearance and Validation for AI-Powered Application to Support Chest X-ray Triage and PrioritizationRADLogics announced that its AI-powered chest X-ray application for pneumothorax detection has received FDA 510(k) clearance. The software is designed to analyze images and flag suspected collapsed lungs for urgent radiologist review, integrating into existing clinical workflows via the Nuance AI Marketplace. This regulatory approval allows healthcare providers in the U.S. to immediately access the tool to improve triage efficiency and support acute care teams.PrwebRADLogics Expands Leadership Team to Support Rapid Scaling of Medical Imaging AI PlatformRADLogics appointed Linda McManus as Executive Vice President and General Manager for the Americas to lead the scaling of its medical imaging AI platform, particularly within the U.S. market. The company's AI-powered applications for evaluating COVID-19 patients are currently available on the Nuance AI Marketplace, leveraging a strategic partnership with Nuance to reach thousands of clinicians.PrwebRADLogics' AI-Powered Applications Supporting the Evaluation of COVID-19 Patients are Now Available on the Nuance AI Marketplace for Diagnostic ImagingRADLogics announced that its AI-powered medical imaging applications for evaluating COVID-19 patients are now available on the Nuance AI Marketplace. This partnership expands access to RADLogics' triage and disease extent measurement tools, which process CT and X-ray scans via a cloud-based platform.HackerNoonOn Guard Against COVID-19: AI Projects That Deserve a Shout-Out | HackerNoonAI projects for COVID-19 detection, PPE compliance, and clinical trial search are highlighted, including RADLogics' CT analysis tool with 98.2% sensitivity and 92.2% specificity, and ViTech Lab's PPE detection system. These tools aim to flatten the infection curve and support vaccine R&D.IEEE SpectrumHospitals Deploy AI Tools to Detect COVID-19 on Chest ScansOver the past week, companies worldwide announced AI-based systems to detect COVID-19 on chest scans, aiding in screening and monitoring disease progression. RADLogics reported up to 98 percent accuracy for its AI system, which has been deployed in various countries including China, Russia, and Italy. The technology aims to alleviate the burden on radiologists while enhancing patient management during the pandemic.PR NewswireSuzhou, China-based ChainZ Medical Technology Co. integrates RADLogics™ Virtual Resident™ AI solution for more efficient and accurate medical imaging interpretationRADLogics announced at RSNA's annual meeting that Suzhou-based ChainZ Medical Technology Co. has selected the RADLogics Virtual Resident AI solution to integrate with its Smart Cloud PACS/RIS system, which serves radiologists in China. The integrated solution will allow radiologists at ChainZ's 380+ hospital clients across Jiangsu, Liaoning, and Shaanxi provinces to access automated image analysis, measurements, and characterization of findings directly within their workflow. RADLogics CEO stated that the partnership will provide benefits to patients, hospitals, and radiologists, supported by UCLA research indicating the technology can reduce interpretation time while improving report accuracy.PrwebRADLogics to Showcase at RSNA 2017 First-of-a-kind Clinical Study Results of its Virtual-Resident™ — Machine Learning Image Analysis Clinical Decision Support SolutionRADLogics will showcase its Virtual Resident software at RSNA 2017, based on a UCLA study showing it saves radiologists up to 47% of reporting time. The study also found nodule detection rates comparable to radiologists and measurements consistent within 1mm. The company will demonstrate the system at Booth #8146.PrwebRadLogics Showcases Machine Learning Image Analysis Solution for Radiologists at RSNA 2016RADLogics will showcase its AlphaPoint machine learning image analysis software at RSNA 2016, demonstrating CT and X-ray studies with automated preliminary reports. The cloud-based service uses machine learning and big data analytics to improve speed, accuracy, and consistency in radiology reporting.